Bank Of New York Mellon Corp Biocryst Pharmaceuticals Inc Transaction History

Bank Of New York Mellon Corp

$538 Trillion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$7.94 - $11.84 $5.32 Million - $7.94 Million	670,608 New	670,608 $5.59 Billion
Q4 2022 Feb 14, 2023	BUY	$10.5 - $14.2 $7.11 Million - $9.61 Million	677,022 New	677,022 $7.77 Million
Q3 2022 Nov 14, 2022	BUY	$10.79 - $14.81 $556,127 - $763,322	51,541 Added 8.31%	671,412 $8.46 Million
Q2 2022 Aug 15, 2022	SELL	$7.89 - $17.88 $2.15 Million - $4.87 Million	-272,237 Reduced 30.52%	619,871 $6.56 Million
Q1 2022 May 11, 2022	BUY	$11.56 - $19.76 $395,074 - $675,317	34,176 Added 3.98%	892,108 $14.5 Million
Q4 2021 Feb 11, 2022	BUY	$11.18 - $15.46 $1.23 Million - $1.7 Million	110,111 Added 14.72%	857,932 $11.9 Million
Q3 2021 Nov 12, 2021	BUY	$14.21 - $17.65 $135,108 - $167,816	9,508 Added 1.29%	747,821 $10.7 Million
Q2 2021 Aug 11, 2021	BUY	$9.5 - $17.24 $222,414 - $403,622	23,412 Added 3.27%	738,313 $11.7 Million
Q1 2021 May 13, 2021	SELL	$7.37 - $13.61 $318,391 - $587,965	-43,201 Reduced 5.7%	714,901 $7.27 Million
Q4 2020 Feb 09, 2021	BUY	$3.37 - $8.61 $106,721 - $272,661	31,668 Added 4.36%	758,102 $5.65 Million
Q3 2020 Nov 12, 2020	SELL	$3.43 - $5.53 $358,380 - $577,796	-104,484 Reduced 12.57%	726,434 $2.5 Million
Q2 2020 Aug 12, 2020	BUY	$1.9 - $5.61 $342,532 - $1.01 Million	180,280 Added 27.71%	830,918 $3.96 Million
Q1 2020 May 06, 2020	BUY	$1.6 - $4.11 $170,939 - $439,100	106,837 Added 19.65%	650,638 $1.3 Million
Q4 2019 Feb 14, 2020	BUY	$1.59 - $3.45 $173,502 - $376,467	109,121 Added 25.1%	543,801 $1.88 Million
Q3 2019 Nov 07, 2019	SELL	$2.5 - $3.73 $44,005 - $65,655	-17,602 Reduced 3.89%	434,680 $1.25 Million
Q2 2019 Aug 12, 2019	SELL	$2.91 - $9.15 $1.31 Million - $4.12 Million	-450,378 Reduced 49.89%	452,282 $1.71 Million
Q1 2019 May 14, 2019	BUY	$7.38 - $9.72 $2.65 Million - $3.5 Million	359,634 Added 66.23%	902,660 $7.35 Million
Q4 2018 Feb 11, 2019	BUY	$6.51 - $9.6 $795,528 - $1.17 Million	122,201 Added 29.04%	543,026 $4.38 Million
Q3 2018 Nov 09, 2018	BUY	$5.52 - $7.99 $69,242 - $100,226	12,544 Added 3.07%	420,825 $0
Q2 2018 Aug 06, 2018	SELL	$4.6 - $6.52 $248,809 - $352,660	-54,089 Reduced 11.7%	408,281 $2.34 Million
Q1 2018 May 15, 2018	SELL	$4.35 - $5.82 $7,921 - $10,598	-1,821 Reduced 0.39%	462,370 $2.21 Million
Q4 2017 Feb 09, 2018	BUY	$4.16 - $5.33 $1.93 Million - $2.47 Million	464,191	464,191 $2.28 Million

Others Institutions Holding BCRX

# of Institutions

279

Shares Held

172M

Call Options Held

625K

Put Options Held

739K

Vanguard Group Inc Valley Forge, PA

20.3M
Shares

$154 Million
0.0% of portfolio
Black Rock Inc. New York, NY

20M
Shares

$152 Million
0.0% of portfolio
Avoro Capital Advisors LLC New York, NY

11.9M
Shares

$90.2 Million
1.36% of portfolio
Kynam Capital Management, LP Princeton, NJ

9.09M
Shares

$69 Million
5.66% of portfolio
State Street Corp Boston, MA

8.85M
Shares

$67.3 Million
0.0% of portfolio

View Full List

About BIOCRYST PHARMACEUTICALS INC

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $1.41B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

More about BCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account